Continuing shift of focus from in vivo
testing to in vitro testing (on human cell lines)
In today’s industry, drug manufacturers want early tests that accurately reflect how a new compound will react in the human body. The industry is searchingfor new paradigms, such as human cell lines, to use in specialized, novel in vitro environments. The goal is to provide a more comprehensive and accurate picture of a drug’s likelihood to succeed, which may not always be the case in an animal model.